Seer SEER
NASDAQ SEER
$1.95 +0.01 (+0.52%)
As of: Sep 4, 2026 · 1:03 PM EDT

Seer (SEER) Equity Income (2024 - 2026)

Analysis

Seer (SEER) Equity Income (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - 4.08 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Seer 107.57 Mn 107.57 Mn 1.51 Mn -2.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.09 Mn
Mar 31, 2026 -1.73 Mn
Dec 31, 2025 -1.08 Mn
Sep 30, 2025 -1.42 Mn
Jun 30, 2025 -1.84 Mn
Mar 31, 2025 -1.58 Mn
Dec 31, 2024 -1.79 Mn
Sep 30, 2024 -861,000.00